Novartis Ag (NVS) Goodwill (2009 - 2026)

Novartis Ag's Goodwill history runs 12 years deep, the most recent figure standing at $1.4 billion for Q1 2026.

• In Q1 2026, Goodwill changed N/A year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $1.4 billion (changed N/A YoY), while the FY2025 annual figure was $25.6 billion, up 3.28% from the prior year.
• Goodwill came in at $1.4 billion for Q1 2026 at Novartis Ag, down from $25.6 billion in the prior quarter.
• In the past five years, Goodwill ranged from a high of $29.5 billion in Q2 2023 to a low of $148.0 million in Q1 2022.
• A 5-year average of $19.5 billion and a median of $25.2 billion in 2024 frame the typical range for Goodwill.
• Across the five-year window, Goodwill jumped 32.14% in 2022 and slipped 20.34% in 2023, its largest moves.
• Novartis Ag's Goodwill stood at $29.3 billion in 2022, then declined by 20.34% to $23.3 billion in 2023, then grew by 6.06% to $24.8 billion in 2024, then climbed by 3.28% to $25.6 billion in 2025, then sank by 94.52% to $1.4 billion in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $1.4 billion, $25.6 billion, and $25.6 billion for Q1 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison